A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
Clinical trial NCT03137927 · COMPLETED
Trial details
- NCT number
- NCT03137927
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2017-12-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.